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Abstract  26 
In vivo and ex vivo imaging was used to investigate the function of galectin-3 (Gal-3) 27 
during the process of leukocyte recruitment to the inflamed microcirculation.  The 28 
cremasteric microcirculation of wild-type (C57BL/6), Gal-3-/- and CX3CR1gfp/+ mice 29 
was assessed by intravital microscopy following PBS, IL-1β, TNF-α or recombinant 30 
Gal-3 treatment.  These cellular responses were investigated further using flow-31 
chamber assays, confocal microscopy, flow cytometry, PCR analysis and proteome 32 
array.  We show that mechanisms mediating leukocyte slow rolling and emigration 33 
are impaired in Gal-3-/- mice, which could be due to impaired expression of cell 34 
adhesion molecules and an altered cell surface glycoproteome.  Local (intrascrotal) 35 
administration of recombinant Gal-3 to wild-type mice resulted in a dose-dependent 36 
reduction in rolling velocity associated with increased numbers of adherent and 37 
emigrated leukocytes, approximately 50% of which were Ly6G-positive neutrophils.  38 
Intrascrotal administration of Gal-3 to CX3CR1gfp/+ mice confirmed that 39 
approximately equal numbers of monocytes are also recruited in response to this 40 
lectin.  Exogenous Gal-3 treatment was accompanied by increased pro-inflammatory 41 
cytokines and chemokines within the local tissue.  In conclusion, this study unveils 42 
novel biology for both exogenous and endogenous Gal-3 in promoting leukocyte 43 
recruitment during acute inflammation. 44 
























Introduction  46 
 47 
Inflammation is a vital response to tissue injury or infection. Its effectiveness relies on 48 
the trafficking of leukocytes, predominantly neutrophils initially, to the site of injury. 49 
In acute inflammation this neutrophilic infiltrate is short-lived due to the co-ordinated 50 
release of pro-resolution mediators that terminate neutrophil recruitment and promote 51 
their efferocytosis leading to a return to homeostasis (1, 2). In chronic inflammation 52 
this resolution process fails and the leukocytic infiltrate becomes persistent, with, in 53 
the case of pathologies such as rheumatoid arthritis, repeated infiltration of 54 
neutrophils into the inflamed joint (3). Understanding the mechanisms by which 55 
leukocytes traffic from the bloodstream to the inflammatory site has been the focus of 56 
intense research over the past two decades and the leukocyte recruitment cascade is 57 
now a well-defined paradigm (4, 5). Although many of the adhesion molecules that 58 
drive this process have been identified, it is evident that leukocyte recruitment is 59 
multi-factorial and relies on the co-ordinated actions of many lipids and proteins 60 
including cytokines and chemokines, as well as the adhesion molecules themselves.  61 
Galectins, represent a family of proteins that have been ascribed pro-adhesive as well 62 
as chemotactic properties, however their role in neutrophil trafficking has not been 63 
systematically studied. Here we have focused on Galectin-3 (Gal-3), a molecule 64 
thought to have predominantly pro-inflammatory functions.  65 
Galectins are a family of beta-galactoside binding proteins that elicit their effects by 66 
binding to exposed N-acetyllactosamine residues on cells (6). Specifically, Gal-3 67 
binds glycoproteins that have been post-translationally modified by the 68 
glycosyltransferase Mgat5 (β1,6-N-acetylglucosaminyl transferase 5), which is 69 
responsible for the addition of β1,6 branched N-acetylglucosamine to the α-linked 70 
mannose of biantennary N-linked oligosaccharides (7). Since its characterization, Gal-71 
3 has been implicated in a range of pathologies, many of which involve both acute 72 
and chronic inflammatory responses characterised by neutrophil infiltration. Levels of 73 
Gal-3 are increased during inflammation, both systemically and locally at the 74 
inflammatory site. In rheumatoid arthritis, Gal-3 localizes to sites of joint destruction 75 
in the synovium, with increased levels of the protein also found in sera and synovial 76 
fluids when compared to those from healthy controls or osteoarthritis patients (8). 77 
























heart failure with levels of this lectin in excess of 50ng/ml detectable (9, 10). In 79 
murine models of inflammation, elevated levels of Gal-3 in exudates has been found 80 
to correlate with increased neutrophil recruitment to the inflammatory site (11).  81 
 82 
Due to its increased production during inflammation and the correlation between the 83 
presence of Gal-3 in inflammatory exudates and neutrophil infiltration we sought to 84 
determine whether Gal-3 directly modulates the leukocyte recruitment process 85 
undertaken by neutrophils as they traffic from the blood to the tissue. We have 86 
addressed the role of both the endogenous protein, through the use of Gal-3 null mice 87 
as well as the function of the recombinant protein. We have demonstrated for the first 88 
time that endogenous Gal-3 is specifically involved in leukocyte slow rolling and that 89 
the recombinant protein initiates recruitment of both neutrophils and monocytes to the 90 
cremaster microcirculation in an in vivo model of inflammation. 91 
 92 
























Materials and methods 94 
Animals 95 
Breeding founders for the Gal-3-/- mouse colony were obtained from the Consortium 96 
for Functional Glycomics on a C57BL/6 background and a colony was established at 97 
Charles River UK.  Male mice bearing green fluorescent protein (GFP) under their 98 
CX3/CR1 promoter were kindly donated by Prof. S. Nourshargh at the Centre for 99 
Microvascular Research, QMUL, London.  In all experiments age and sex-matched 100 
controls [wild type (WT) C57BL/6] were also purchased from Charles River UK.  All 101 
animals were fed standard laboratory chow and water ad libitim and were housed in a 102 
12h light-dark cycle under specific pathogen-free conditions.  All experiments were 103 
performed with mice (20-28g), strictly following UK Home Office regulations 104 
(Guidance on the Operation of Animals, Scientific Procedures Act, 1986). 105 
   106 
Reagents  107 
Recombinant mouse IL-1β and TNF-α and Power SYBR Green Mastermix were 108 
purchased from ThermoFisher Scientific (MA, USA). PE conjugated-anti-mouse 109 
Ly6g (Clone 1A8) and FITC-conjugated Ly-6G were purchased from BD 110 
Pharmingen. PE-conjugated Gal-3 (clone M3/83), PE-conjugated IgG2a isotype 111 
control (clone eBR2a), PE-conjugated CD11b (clone M1/70), APC-conjugated L-112 
selectin (CD62L) (clone MEL-14), APC-conjugated IgG2a κ and PE-conjugated 113 
IgG2b k isotype controls, murine FC block and multi species 10x red blood cell lysis 114 
buffer were all purchased from eBiosciences (Hatfield, UK). Alexa Fluor® 488 Ly-115 
6C (clone HK1.4) and pacific blue-conjugated Ly-6G (clone 1A8) were from 116 
Biolegend (Cambridge, UK). Streptavidin PE-conjugated secondary antibody was 117 
from Invitrogen (Paisley, UK). Alexa Fluor 488 conjugated fibrinogen was from 118 
Fisher Scientific (Loughborough, UK). Recombinant mouse E-selectin Fc Chimera, 119 
recombinant mouse ICAM-1 Fc Chimera and the mouse cytokine array panel A 120 
Proteome Profiler™ were from R&D Systems (Abingdon, UK). Alexa Fluor® 555 121 
conjugated VE-Cadherin and Alexa Fluor® 647 conjugated MRP14 were kindly 122 
supplied by S.N.). Histopaque 1119 and 1077 was from Sigma Aldrich (Dorset, UK). 123 
Recombinant Gal-3 was kindly supplied by GalPharma Inc. (Japan). The following 124 
lectins were purchased from Vector Laboratories (Peterborough, UK): HPA, SNA, 125 

























Intravital microscopy  128 
Intravital microscopy of the cremaster muscle was carried out as previously described 129 
(12).  Male mice were anaesthetised with Isofluorane gas before an intrascrotal (i.s.) 130 
injection of PBS (sham), IL-1β (30ng), TNF-α (300ng) or Gal-3 (200-1000ng) in a 131 
final volume of 400μl.  The injection was carried out 2 or 4h before the vessel was 132 
recorded, allowing time for the 30min stabilization period after the surgery had been 133 
completed.  Prior to the i.s. injection, some animals also underwent a tail-vein 134 
intravenous (i.v.) injection of fluorescent antibody, rat anti-mouse Ly-6G (2μg) in 135 
200μL saline.  Briefly, mice were anaesthetised using a mixture of xylazine (7.5 136 
mg/kg; Rompun) and ketamine (150 mg/kg; Narketan) by intraperitoneal (i.p.) 137 
injection.  The cremaster muscle was exteriorised and secured over the viewing stage; 138 
throughout the recordings it was superfused with bicarbonate buffered solution (BBS) 139 
held at 37°C.  Brightfield recordings were carried out using a Zeiss Axioskop FS 140 
microscope (Carl Zeiss Ltd). Fluorescence microscopy was carried out using an 141 
Olympus BX61W1 microscope (Carl Zeiss Ltd.) connected to an Olympus BXUCB 142 
lamp, Uniblitz VCMD1 shutter driver and DG4-700 shutter instrument and recordings 143 
captured using Slidebook 5.0 software (Intelligent Imaging TTL).  An Optical 144 
Doppler Velocimeter (Microvascular Research Institute, Texas A&M University) was 145 
used to ensure centerline red blood cell velocity remained adequate.  Vessel segments 146 
of 100μm in post-capillary venules with a diameter of 20-40 μm, an adequate 147 
centerline velocity (≥500 s-1) and no branches within 100μm either side of the 148 
segment to be analysed were chosen.  Leukocyte rolling velocity (μm/s), adhesion 149 
(>30 s stationary) and emigration (50 μm by 100 μm either side of vessel) were 150 
quantified. 151 
 152 
Ex vivo flow chamber assay 153 
This assay was used to assess leukocyte behaviour under conditions of flow, which 154 
were generated using an automated syringe pump (Harvard Apparatus) connected to 155 
small-diameter tubing and chamber slides allowing observation of the leukocytes over 156 
a layer of recombinant E-Selectin.  Ibidi μ-Slide VI0.4 cell microscopy chambers 157 
were coated with recombinant mouse E-selectin Fc Chimera (2μg/ml) in 100μL 158 
PBS/well for 2h at room temperature.  The wells were blocked using 0.5% Tween-20 159 
in PBS for 1h at room temperature.  Murine whole blood was collected by cardiac 160 
























the chamber at 1.010ml/min for 3min.  This was followed by HBSS at the same rate 162 
for 1min before image acquisition and subsequent offline analysis.  In some 163 
experiments the whole blood was pre-treated for 15min at 37°C with recombinant 164 
Gal-3 (rGal-3; 10ng/ml) prior to flow.  The flow chamber slides were viewed using a 165 
Nikon Eclipse TE3000 and 6 10s frames were collected for each well using a Q-166 
Imaging Retiga EXi Digital Video Camera (Q-Imaging); recordings were analysed 167 
using Image Pro-Plus software (Media cybernetics). 168 
 169 
In a further series of experiments crawling of bone marrow leukocytes on ICAM-1 170 
was assessed. Cells were isolated from the tibias and femurs of mice as described 171 
previously (13). Briefly, bones were flushed with RPMI containing 10% FCS and 172 
2mM EDTA and the resulting cell suspension was passed through a 100μm filter. 173 
Following hypotonic lysis of red blood cells with 0.2% NaCl, cells were washed in 174 
RPMI and resuspended in 1ml of ice-cold PBS. Cells were layered onto a double 175 
density gradient of histopaque and centrifuged for 30 min at 2,000 rpm without brake. 176 
Neutrophils were then collected from the interface between the 1119 and 1077 177 
histopaque layers, counted and resuspended at 1 x 106/ml. Ibidi chamber slides were 178 
coated with recombinant mouse ICAM-1 Fc Chimera (2.5μg/ml). Bone marrow 179 
neutrophils were stimulated with TNFα (10ng/ml) and allowed to adhere within the 180 
chamber for 5 mins. HBSS was then flowed through the chamber at 2dyne/cm2 and 181 
frames were recorded every 10 sec for 15 mins as described above. Cell crawling was 182 
analyzed using the cell-tracking function in ImageJ software, and tracks were 183 
analyzed utilizing Ibidi Chemotaxis and Migration Tool. Only cells that started and 184 
remained within the field of view over the entire course of video capture were 185 
analyzed. At least 45 cells were tracked per mouse. 186 
 187 
Analysis of leukocyte glycosylation profile, cell adhesion molecule expression and 188 
integrin activation. 189 
Gal-3-/- or WT mice were deeply anaesthetised and up to 900μL of blood was 190 
collected by cardiac puncture into heparin-coated syringes (100μL of 100U/mL).  191 
Murine whole blood was treated for 15min at 37°C with PBS (Sham), murine IL-1β 192 
(1-100ng/ml) or murine TNF-α (10-200ng/ml) before centrifuging at 300 g for 5 min 193 
and aspiration of the supernatant.  Cells were resuspended in murine FC Block 194 
























antibodies were added directly to the wells and incubated for 45min on ice in the 196 
dark: PE-conjugated Gal-3 (8μg/ml), PE-conjugated IgG2a isotype control (8μg/ml), 197 
FITC-conjugated Ly-6G (5μg/ml), PE-conjugated CD11b (2μg/ml), PE-conjugated 198 
IgG2b k (2μg/ml), APC-conjugated L-selectin (1μg/ml), APC-conjugated IgG2a κ 199 
(1μg/ml), Alexa Fluor® 488 Ly-6C (2.5μg/ml).  Red blood cells were lysed with 200 
multi-species lysis buffer and the plate was washed twice in PBS-BSA before samples 201 
were transferred to flow cytometry tubes in 2% PFA and analysed on a FACSCalibur 202 
(BD Biosciences).   203 
 204 
To assess CD11b activation, bone marrow neutrophils were stimulated with fMet-205 
Leu-Phe (fMLP; 1μM) or Phorbol 12-myristate 13-acetate (PMA; 50ng/ml) for 15 206 
mins in the presence of Alexa Fluor conjugated fibrinogen (250μg/ml). Neutrophils 207 
were subsequently labelled with pacific blue-conjugated Ly-6G (1.25μg/ml) and 208 
fibrinogen binding on the Ly-6G positive population was assessed on a BD 209 
LSRFortessa.  210 
 211 
For the lectin binding assay, murine whole blood immediately underwent red cell 212 
lysis and following this were incubated with FC Block (0.5μg/mL) for 10 min before 213 
the addition of the following antibodies and biotinylated lectins for 45 min at room 214 
temperature: FITC-conjugated Ly-6G (5μg/ml), Alexa Fluor® 488 Ly-6C (2.5μg/ml), 215 
HPA (20μg/ml), SNA (166ng/ml), PNA (20μg/ml), MAL II (3.3μg/ml) and Phaseolus 216 
vulgaris leucoagglutinin (L-PHA; 4μg/ml; Vector Laboratories).  The cells underwent 217 
incubation for 30 min at room temperature with a streptavidin PE-conjugated 218 
secondary antibody (120ng/ml in PBS-BSA) and fixation in 2% PFA before analysis 219 
on a FACSCalibur.   220 
 221 
Isolation of murine lung endothelial cells  222 
Murine lung endothelial cells (MLEC) were isolated from the lungs of Gal-3-/- or 223 
WT mice as described previously (14). Briefly, lungs were excised and placed in 224 
Ham’s F12 media (Gibco) on ice.  Following maceration, the tissue was further 225 
digested in 10mL 1mg/mL collagenase Type I-S for 2h at 37°C.  The digest was 226 
diluted in 10mL MLEC media (equal parts low glucose DMEM and Ham’s F12 227 
























(100μg/mL) and L-Glutamine (2mM; Sigma), endothelial cell growth supplement 229 
(25μg; AbD Serotech) and 20% FCS) and passed through a 19.5G needle followed by 230 
a 70μm cell-strainer (BD Falcon).  The resulting cell suspension was cultured in 231 
flasks pre-coated with 10mL 0.1% Gelatin in PBS containing bovine collagen 232 
(30μg/mL, 97% Type I 3% type III; Nutacon) and bovine plasma fibronectin 233 
(10μg/mL; Sigma). 234 
 235 
Endothelial cells were first purified by removal of contaminating macrophages using 236 
Dynabeads ((10μL/3mL); Dynal Biotech) and a rat anti-mouse CD16/32 (5μg/3mL; 237 
BD Biosciences) antibody. Sorted cells were then cultured until colonies of 238 
approximately 20 endothelial cells could be seen. 239 
 240 
The culture was purified further by positive selection for the ndothelial cells using 241 
ICAM-2/CD102 [Clone 3C4(mIC2/4); 10μg/3mL; BD Pharmingen].  10mL MLEC 242 
media was used to resuspend the cells, which were then cultured until they reached 243 
50% confluence, at which point the positive sort was repeated to enhance the culture. 244 
 245 
Analysis of murine endothelial cell adhesion molecule expression  246 
WT and Gal-3-/- MLEC were treated for 4 hours with PBS (sham) or murine IL-1β (1-247 
100ng/mL) and then detached using Accutase.  Cells were incubated with murine Fc 248 
Block (0.5μg/mL; eBiosciences).  The following rat anti-mouse primary antibodies 249 
were added directly to the cells with Fc Block and incubated on ice: PE-conjugated 250 
CD31 (clone MEC 13.3, 4μg/mL; BD Pharmingen), PE-conjugated CD54 (clone 251 
YN1/1.7.4, 2μg/mL; eBioscience), PE-conjugated IgG2bκ (2μg/mL; eBioscience), 252 
FITC-conjugated CD102 (clone 3C4, 10μg/mL; BD Pharmingen), purified CD62E 253 
(clone 10E9.6, 5μg/mL; BD Pharmingen).  Cells were washed twice in PBS-BSA and 254 
transferred to flow cytometry tubes in 2% PFA before analysis on a FACSCalibur.   255 
 256 
Ex vivo confocal microscopy of the cremaster 257 
Cremasters from CX3/CR1 GFP mice were exteriorised and fixed in 4% PFA before 258 
permeabilisation and blocking in PBS containing 12.5% each of fetal bovine serum 259 
(FBS) and NGS and 0.5% Triton-X-100 for 2h at room temperature.  Primary 260 
























Fluor® 647 conjugated) were applied overnight at 4°C and the vessels were viewed 262 
using a Leica SP5 confocal microscope using a resonance scanner of 8000 Hz. 263 
 264 
Assessment of murine cremaster mRNA 265 
Murine cremaster muscles were dissected and snap frozen in LN2 before tissue 266 
disruption using the Precellys 24 tissue homogeniser (5500 g, 3 × 20 s). The 267 
supernatant was further disrupted by passage through a 27G syringe before RNA 268 
isolation with the RNeasy kit and on-column DNase. RNA was reverse transcribed 269 
into cDNA. Quantitative real time PCR was performed using Power SYBR Green 270 
Mastermix (Applied Biosystems).  Primers included those for Lgals3, Gapdh, Rpl32, 271 
Il-1b, tnf, Il-6, Ccl2, Cxcl1, Cxcl12, Ly-6G, Csf1r, Pecam1, Icam1 and Sele. Thermal 272 
cycling was carried out using the ABI Prism® 7900 Real Time PCR system according 273 
to manufacturer recommendations. The comparative Ct method (15) was used to 274 
measure gene transcription, where the Ct values were first normalised with an 275 
endogenous housekeeping gene and then to the control samples, which were used as a 276 
calibrator and given a value of 1 and the results were expressed as relative units based 277 
on 2-ΔΔCt. 278 
 279 
Protein expression of cytokines and chemokines in the cremaster 280 
Murine cremaster muscles were dissected and snap frozen in LN2 before disruption in 281 
600μL PBS containing protease inhibitors Aprotinin, Leupeptin and Pepstatin (all 282 
10μg/ml) using the Precellys 24 tissue homogeniser (600 g, 2 × 30 s).  The 283 
supernatant was collected and 1% Triton-X-100 was added before the samples 284 
underwent freezing at -80°C.  After thawing the samples were centrifuged at 10,000 g 285 
for 5 min.  A final protein quantity of 200 μg was then assessed using the mouse 286 
cytokine array panel A Proteome Profiler™ according to manufacturer instructions.   287 
 288 
Statistical analysis 289 
All data were analysed using GraphPad Prism 4 software.  Data are expressed as 290 
mean±standard error of the mean (SEM) of n experiments.  All data were tested for 291 
normal distribution.  Statistical significance was assessed using unpaired students t-292 
tests, one-way analysis of variance (ANOVA) or two-way ANOVA with the 293 
appropriate post hoc test, commonly Dunnett’s post-test or the Tukey range test.  In 294 

















































Results  298 
Endogenous Gal-3 is required for reduction in leukocyte rolling velocity in 299 
response to TNFα and IL-1β, and leukocyte emigration in response to IL-1β, in 300 
inflamed post-capillary venules 301 
The cremasteric microcirculation of Gal-3-/- mice was assessed after 4h treatment with 302 
TNFα (300ng) or IL-1β (30ng), reflecting the time taken to see significant changes in 303 
leukocyte recruitment in wild type mice (Fig. 1A-C). It is well established that these 304 
two stimuli are important pro-inflammatory modulators of the acute inflammatory 305 
response (16, 17) as well as in chronic pathologies, for example rheumatoid arth itis 306 
(18, 19).  The administration of these cytokines in vivo results in leukocyte 307 
recruitment that may differ in mode; for example, an early study examining responses 308 
to both cytokines intradermally in the rabbit found that IL-1β-induced neutrophil 309 
extravasation peaked at 3-4h whereas TNFα-induced neutrophil extravasation was 310 
much quicker and also associated with protein synthesis-independent oedema 311 
formation (20). Following TNFα treatment, Gal-3-/- mice displayed similar levels of 312 
leukocyte adhesion (Fig. 1B and D) and emigration (Fig. 1C and D); however, they 313 
lacked the reduction in rolling velocity observed in wild type animals that is 314 
characteristic of E-selectin-dependent rolling (Fig, 1A) (21). A similar observation 315 
was made in mice treated with IL-1β (30ng) where average rolling velocity was 316 
reduced in wild type mice but not in Gal-3-/- animals (Fig. 1A). In addition, 317 
significantly fewer leukocytes emigrated in Gal-3-/- mice after IL-1β treatment when 318 
compared to wild-type animals, a reduction that was not observed in response to 319 
TNFα (Fig. 1C).  320 
 321 
Leukocyte binding to E-selectin and subsequent cellular morphological changes 322 
are disrupted in the absence of endogenous Gal-3 323 
Since leukocyte rolling is dependent on selectin binding, with slow rolling 324 
predominantly mediated by E-selectin in this model (21), we next examined the role 325 
of Gal-3 in E-selectin-dependent rolling in greater depth. Experiments were 326 
performed under flow whereby whole blood from C57BL/6 or Gal-3-/- mice was 327 
flown through chambers coated with recombinant E-selectin. We show that under 328 
conditions of flow, Gal-3-/- leukocytes exhibit a reduced capacity to adhere to E-329 
























leukocyte behaviours were observed; some cells remained phase bright, whereas some 331 
leukocytes displayed a more active phenotype and changed their morphology to 332 
become phase dark (Fig. 2C), likely due to E-selectin ligation, which initiates 333 
intracellular signalling pathways leading to neutrophil activation (22). We found that 334 
a smaller proportion (percentage of total cells) of Gal-3-/- cells displayed phase dark 335 
morphology when compared to wild type cells (Fig. 2B). This phenotype was not 336 
rescued by the addition of plasma levels (10ng/ml, as assessed by ELISA) of rGal-3 to 337 
Gal-3-/- blood (Fig. 2D). Importantly, there was no significant difference in white 338 
blood cell count (cells/μl) between wild type and Gal-3-/- mice (WT 29.92±0.17 vs. 339 
KO 28.00±3.41, n.s); consequently, any differences observed can be attributed to 340 
changes in the leukocytes themselves. This is in line with full haematological reports 341 
published on the Consortium for Functional Genomics, which find no differences in 342 
Gal-3-/- leukocyte cell counts when compared to wild type mice (23). These results 343 
suggest that in the absence of Gal-3, the cells lack the machinery needed to bind E-344 
selectin and facilitate the downstream signalling pathways that are initiated once 345 
bound; thus, E-selectin ligands were studied in greater depth. 346 
 347 
Murine neutrophils display reduced PNA and HPA lectin binding sites on their 348 
cell surface.   349 
Since there have been no reports of direct interactions between galectins and selectins, 350 
we hypothesised that lack of endogenous Gal-3 may affect the availability of selectin 351 
ligands.  All selectin ligands carry sLex, commonly on α1,3-fucosylated and α2,3-352 
sialylated O-glycans; though they are less well understood, E-selectin ligands 353 
specifically must be modified by a fucosyltransferase such as fucosyltransferase VII 354 
or IV to be functional.  Hence the glycosylation pattern of Gal-3-/- leukocytes was 355 
assessed, as any inherent changes would greatly affect the ability of E-selectin ligands 356 
such as ESL-1, PSGL-1 and CD44 to bind. Since untreated Gal-3-/- leukocytes 357 
exhibited reduced capture to E-selectin under conditions of flow, basal levels of lectin 358 
binding by neutrophils was analysed by flow cytometry. This was carried out using 359 
cell markers and a panel of biotinylated lectins, which each bind glycans of different 360 
structures. When compared to their wild type counterparts, Gal-3-/- neutrophils were 361 
found to display comparable binding of the lectins SNA, L-PHA and MAL II but 362 

























Cells lacking endogenous Gal-3 display altered ligand expression in response to 365 
IL-1 β and TNFα. 366 
We previously observed that endogenous Gal-3 is required for complete leukocyte 367 
emigration in response to IL-1β but not TNFα.  These two classical stimuli are known 368 
to have differing and cell type-specific roles; IL-1β activates the endothelia directly 369 
whereas wild type neutrophils respond to TNFα by increasing their expression of β2-370 
integrin (CD18) and shedding L-selectin (24).  We therefore assessed the effects of 371 
these two stimuli on adhesion molecule expression of wild type and Gal-3-/- 372 
leukocytes (Fig. 4).   373 
 374 
Wild type or Gal-3-/- whole blood was treated for 10min at 37°C with vehicle (PBS), 375 
TNFα (50ng/mL) or IL-1β (50ng/mL) before cell staining with antibodies against 376 
CD11b and L-selectin as well as the neutrophil marker Ly-6G (Clone 1A8). In 377 
contrast to treatment with IL-1β, which did not alter expression from vehicle treated 378 
cell levels; treatment with TNFα increased neutrophil expression of CD11b in wild 379 
type cells (Fig. 4A). Furthermore, when compared to their wild type counterparts, 380 
Gal-3-/- neutrophils exhibited significantly reduced levels of CD11b basally and after 381 
cytokine treatment (Fig. 4A). To assess whether CD11b activation is also reduced in 382 
Gal-3-/- neutrophils, binding of Alexa488-conjugated fibrinogen to bone marrow-383 
derived neutrophils from Gal-3-/- and wild type mice was measured. Stimulation of 384 
neutrophils with PMA (50ng/ml) significantly increased fibrinogen binding to both 385 
Gal-3-/- and wild-type neutrophils compared to untreated cells, however fibrinogen 386 
binding was not significantly different between the two genotypes (supplementary 387 
material Fig. S1A). In line with a lack of difference in CD11b activation between the 388 
two genotypes, there was no difference in neutrophil crawling (distance travelled or 389 
crawling velocity) on recombinant ICAM-1 between TNFα-stimulated bone marrow 390 
neutrophils from Gal-3-/- or wild type mice (supplementary material Fig. S1B and C). 391 
In a similar fashion to CD11b expression patterns in wild type neutrophils, treatment 392 
with TNFα induced L-selectin shedding though IL-1β did not (Fig. 4C). However, L-393 
selectin shedding was unaltered in the Gal-3-/- neutrophils basally and after TNFα 394 

























In order to examine the direct effects of IL-1β on the endothelium, confluent wild 397 
type and Gal-3-/- mEC were treated for 4h with the cytokine (1-100ng/ml). ICAM-1 398 
and E-selectin expression levels were then quantified by flow cytometry. When 399 
compared to their wild type counterparts, Gal-3-/- mEC expressed reduced E-selectin 400 
and ICAM-1 on their surface after IL-1β treatment (Fig. 4E, F). 401 
 402 
Administration of exogenous Gal-3 results in neutrophil and monocyte 403 
recruitment to post-capillary venules.   404 
In addition to its intracellular localisation, Gal-3 is secreted and found extracellularly, 405 
where it exerts its effects predominantly by interacting with glycans on the cell 406 
surface and associated with the extracellular matrix. In order to establish whether 407 
exogenous Gal-3 is capable of initiating leukocyte recruitment to the cremasteric 408 
microcirculation in the absence of a classical inflammogen, a time-course using rGal-409 
3 was carried out.  Intravital microscopy was first performed using wild type 410 
C57BL/6 mice, which were injected i.s. with rGal-3 (500ng) 2 or 4h before 411 
subsequent analysis (Fig. 5). Leukocyte recruitment overall was increased at the 4h 412 
but not the 2h time-point with no significant differences observed between sham-413 
treated animals and those treated with Gal-3 for 2h (Fig. 5A). In comparison, at 4h the 414 
microcirculation displayed significantly reduced leukocyte rolling velocities as well 415 
as significant increases in both adhesion and emigration (Fig. 5A). Once we had 416 
established that Gal-3 could elicit an inflammatory response, we were interested to 417 
establish whether the lectin would act dose-dependently and exhibit cell-type specific 418 
responses.  419 
 420 
Following antibody validation, murine anti-Ly-6G was used to label neutrophils 421 
recruited to the cremaster in C57BL/6 mice treated with rGal-3 (200ng-1000ng in 422 
400uL PBS i.s.). Rolling velocities were significantly reduced from sham levels in 423 
both 500ng and 1000ng-treated mice and this reduction was similar for Ly-6G -ve and 424 
Ly-6G +ve cells (Fig. 5B). Following 1000ng rGal-3 treatment, levels of both 425 
adherent and emigrated cells were significantly increased from sham for both Ly-6G -426 
ve and Ly-6G +ve cells (Fig. 5B). This confirms that in this system exogenous Gal-3 427 
can act specifically to increase neutrophil trafficking to the inflamed area in vivo, 428 
























investigate monocyte recruitment in isolation, the cremasteric microcirculation in 430 
CX3CR1gfp/+ mice was assessed 4h after intrascrotal injection of PBS (sham) or 431 
recombinant rGal-3 (1000ng). Monocyte rolling velocity was significantly reduced 432 
after rGal-3 treatment (Fig. 5D). This was in addition to increased adhesion and 433 
emigration of monocytes to the inflamed rGal-3-treated area (Fig. 5D). These results 434 
were confirmed using cremaster muscles from rGal-3-treated (1000ng) CX3CR1gfp/+ 435 
mice, which were exteriorised and stained using antibodies against VE-Cadherin and 436 
MRP14 (Fig. 5F). Similarly to the vessels analysed by intra-vital microscopy, mice 437 
treated with rGal-3 exhibited increased emigration of both neutrophils and monocytes 438 
when compared to sham-treated animals and these cell types were present in the tissue 439 
in an approximate ratio of 50:50 (Fig. 5G).  440 
 441 
Exogenous Gal-3 treatment results in increased pro-inflammatory cytokine and 442 
chemokine expression in the local tissue microenvironment 443 
In order to further examine the effects of rGal-3 on the tissue after i.s. injection, real-444 
time PCR analysis of expression of various inflammatory genes was carried out. The 445 
cremasters from C57BL/6 mice-treated i.s. with vehicle control (PBS) or rGal-3 446 
(1000ng) were analysed. When compared to their sham-treated counterparts, 447 
cremaster muscle treated with rGal-3 displayed significantly increased mRNA for IL-448 
1β, Keratinocyte-derived chemokine (KC), monocyte chemoattractant protein-1 449 
(MCP-1) and IL-6 and there was a trend for increased TNFα (Fig. 6A). In contrast, 450 
the expression of SDF-1 was not changed in rGal-3-treated cremaster muscle when 451 
compared to sham preparations.  452 
 453 
To confirm that this increase in pro-inflamatory gene expression results in increased 454 
protein, murine cremaster muscles were dissected following intrascrotal treatment for 455 
4 hours rGal-3 (1000ng). Frozen cremasters were homogenised and a final protein 456 
quantity of 200μg was then assessed using the mouse cytokine array panel A 457 
Proteome Profiler™. The proteome array of rGal-3-treated cremaster samples 458 
displayed increased binding of many cytokines and chemokines, when compared to 459 
sham cremaster arrays (Fig. 6B). Cytokines increased after rGal-3 treatment included 460 
IFNγ, MCP-1, IL-6, KC, MIP-1α, MIP-2 (CXCL2) and TNFα. Crucially, these 461 
























were comparable or reduced when compared to control arrays, for example MIP-1β 463 
and BCA-1. 464 
 465 
Administration of recombinant Gal-3 intravenously does not affect leukocyte 466 
recruitment or cell adhesion molecule expression.   467 
Despite treating locally with rGal-3, we wanted to ensure that the lectin was not 468 
entering the systemic circulation and acting on neutrophils and monocytes directly. Of 469 
note here are previous studies suggesting that Gal-3 may act as a soluble adhesion 470 
molecule for neutrophils in vitro, where it increased their binding to endothelial 471 
monolayers (11, 25). Additionally, Gal-3 promotes human neutrophil adherence to the 472 
extracellular matrix proteins laminin and fibronectin. This effect is dependent on the 473 
carbohydrate recognition domain and amino terminal of Gal-3 as well as being 474 
temperature and Ca2+/Mg2+-dependent, suggesting that Gal-3 oligomerizes at the cell 475 
surface (25). Furthermore, when the two cell types are incubated together in vitro, 476 
Gal-3 forms clusters between the endothelial cell surface and adherent neutrophils, 477 
these are concentrated at tricellular corners of the endothelium where these cells 478 
preferentially transmigrate (26). The cremasteric microcirculation was therefore 479 
assessed following intravenous administration of vehicle (saline, 200μL) or 480 
recombinant rGal-3 (150ng). It was found that administration of rGal-3 had no effect 481 
on leukocyte recruitment to the area over a 60 min period, suggesting that exogenous 482 
Gal-3 does not act on leukocytes or vascular endothelial cells directly, at least within 483 
60 min (supplementary material Fig. S2A-D). Furthermore, analysis of leukocytes by 484 
flow cytometry following i.v. administration of rGal-3 revealed that the expression of 485 
CAMs such as PSGL-1, L-selectin, CD44 or CD11a, b and c was unchanged in 486 
response to this lectin (supplementary material Fig. S2E). These results reflect those 487 
seen in the ex vivo flow chamber (Fig. 2D), where rGal-3 did not affect interactions of 488 
leukocytes with E-selectin in isolation. 489 
























Discussion  491 
The goal of this study was to investigate whether Gal-3 acted as a positive regulator 492 
of leukocyte recruitment in vivo. The results reveal previously unreported roles for 493 
Gal-3 in controlling the dynamics of vascular leukocyte recruitment. We have shown 494 
that adhesion molecule expression is compromised in the absence of Gal-3 leading to 495 
reduced leukocyte trafficking in vivo and adhesion/activation in vitro. A pro-496 
recruitment role for Gal-3 is further evidenced by the ability of the recombinant 497 
protein to induce the generation of multiple soluble pro-inflammatory mediators and 498 
to enhance leukocyte transmigration. Overall, these results suggest that Gal-3 is 499 
required for the efficient recruitment of leukocytes during an acute inflammatory 500 
response.  501 
 502 
The actions of galectins are complex and depend on their cellular localisation with 503 
intracellular functions often at odds with their effects once released in the 504 
extracellular environment. This is the case for Gal-3, as the intracellular protein can 505 
inhibit T cell apoptosis (27), whilst extracellular Gal-3 induces apoptosis (28). It is 506 
also apparent that the actions of Gal-3 are stimulus specific, particularly when 507 
considering its role in neutrophil trafficking (29-31). Although previous studies 508 
suggest that Gal-3 facilitates leukocy e recruitment and may even function as an 509 
adhesion molecule when it is prese t in inflammatory exudates (31), its actions on the 510 
leukocyte recruitment cascade have not been detailed. We have therefore addressed 511 
the roles of both the endogenous and the recombinant protein on the inflammatory 512 
response initiated by two major pro-inflammatory cytokines.  513 
 514 
The data presented show that endogenous Gal-3 is required for slow rolling of 515 
leukocytes in response to local treatment with the pro-inflammatory cytokines IL-1β 516 
and TNFα. The response to these cytokines differed however, in terms of the impact 517 
of Gal-3 on leukocyte emigration, providing further evidence of stimulus specific 518 
roles for this lectin. The reduced leukocyte emigration we observed in Gal-3-/- mice is 519 
in keeping with published results. Reduced monocyte, macrophage and neutrophil 520 
recruitment to the CNS occurs in a model of EAE (32) and despite conflicting reports 521 
using a thioglycollate broth model of peritonitis, reduced infiltration of neutrophils 522 
was observed at either day 1 or 4 after insult (33, 34). Farnworth et al. reported that 523 
























recruitment at 15 h after S. pneumoniae infection: of interest, neutrophil recruitment 525 
in this model is independent of β2-integrins (35). This reduction in extravasated 526 
neutrophils at 12-24 h was also reported by Nieminen et al., who found that 527 
recruitment was unaffected in β2-integrin-dependent E. Coli-driven lung infection in 528 
Gal-3-/- animals (36). These studies have led to the hypothesis that Gal-3 may function 529 
as a bona fide adhesion molecule in response to particular stimuli. Our data suggest 530 
that while this may be case, with discrepancies between the response observed to IL-531 
1β versus TNFα, the role of Gal-3 extends beyond models in which the recruitment is 532 
β2-integrin independent. The effects of Gal-3 on leukocyte recruitment we have 533 
identified here are not limited to neutrophils; Gal-3 expression is increased in murine 534 
lungs with allergic asthma and Gal-3-/- mice display reduced lung and airway 535 
eosinophilia in response to acute and chronic ovalbumin challenge, espectively (37). 536 
Further investigation showed endogenous Gal-3 is required for rolling of bone 537 
marrow-derived eosinophils on VCAM-1 and showed a trend to be required for stable 538 
adhesion on ICAM-1 under conditions of flow. This was in addition to its requirement 539 
for subsequent activation-induced morphological changes such as cell spreading and 540 
protrusion formation as well as intracellular Gal-3 being vital for eosinophil migration 541 
to eotaxin-1 in Transwells™ (38).   542 
 543 
Our findings suggest stimulus-specific roles for Gal-3 as evidenced by the different 544 
responses we observed to IL-1β and TNFα in the absence of Gal-3.  Since IL-1β 545 
activates the endothelia directly (24) the differences in leukocyte emigration 546 
quantified in Gal-3-/- mice suggest that endothelial function may be compromised in 547 
these animals, possibly in terms of their expression of CAMs and junctional adhesion 548 
molecules involved in transmigration. Our finding that Gal-3-/- endothelial cells 549 
express reduced ICAM-1 and E-selectin following IL-1β treatment; an outcome that 550 
would have direct consequences for IL-1β-induced slow rolling and possibly 551 
subsequent transmigration suggests that the function of the endothelium is defective 552 
in these mice.  More recently, it was found that neutrophil transmigration elicited by 553 
IL-1β but not TNFα is protein-synthesis dependent and requires ICAM-2, JAM-A 554 
then PECAM-1 in distinct but sequential steps (24, 39).  In future the expression of 555 
these molecules in Gal-3-/- endothelial cells should be assessed as well as their 556 
























interest to this study, IL-1β but not TNFα-induced neutrophil transmigration is 558 
dependent on α6-integrin (43), which is recognised by HPA lectin, one of those found 559 
to exhibit reduced binding in Gal-3-/- cells.  560 
 561 
Furthermore, Young et al showed that wild type neutrophils respond to TNFα by 562 
increasing their expression of β2-integrin (CD18) and shedding L-selectin, in contrast 563 
to cells treated with IL-1β (24). Since Gal-3 is not thought to affect β2-integrin-564 
dependent leukocyte recruitment (36), CD11b, which forms Mac-1 with the β2-565 
integrin CD18, was investigated. Flow cytometric analysis showed that Gal-3-/- 566 
neutrophils express reduced PSGL-1 in response to TNFα, a finding that could have 567 
direct consequences for leukocyte slow rolling since PSGL-1 is a known ligand of E-568 
selectin and these interactions support slow rolling in post-capillary venules (44). 569 
Also Gal-3-/- neutrophils express reduced CD11b basally and after TNFα treatment, 570 
though levels of L-selectin were comparable.  571 
 572 
It is worth noting here that despite this altered cell adhesion molecule expression on 573 
both Gal-3-/- neutrophils and endothelial cells, levels of adhesion were unchanged in 574 
Gal-3-/- mice, both basally and after stimulation. Kubes et al. demonstrated that rolling 575 
needs to be reduced by approximately 90% to affect levels of leukocyte adhesion; 576 
these authors used a high dose of fucoidin, a sulphated homopolymer of fucose, to 577 
attain this level of reduction and determined the ensuing attenuation of reperfusion-578 
induced leukocyte adhesion (45). Furthermore, in wild type mice treated with TNFα 579 
approximately 90% of rolling leukocytes progress to become adherent and in E-580 
selectin-/- mice where rolling velocities remain high, 50% of the rolling leukocytes are 581 
still able to adhere (46). There are several further explanations, which might account 582 
for these differences. In the current study, we have only looked at CD11b expression 583 
and not CD11a and it has been shown in Mac-1 (CD11b) knockout mice that adhesion 584 
is normal due to the presence of CD11a (47), indeed studies have shown that LFA-1 is 585 
the dominant of the two molecules with regards to neutrophil adhesion and migration 586 
(48).  It is possible and likely that in vivo other adhesion molecules compensate for 587 
any reduction in ICAM-1 that might be present in Gal-3-/- mice. In support of this 588 
hypothesis, leukocyte trafficking is relatively normal in ICAM-1 deficient mice in a 589 
























due to the ability of other adhesion molecules such as P- and E-selectin, LFA-591 
1/ICAM-2 or α4β1 integrin. Interestingly optimal rolling in vivo is reliant on ICAM-592 
1, which might be the reason why differences are observed in knockout mice with 593 
regards to rolling velocity rather than adhesion. Steeber et al (50) have shown that at 594 
later time-points during trauma-induced rolling in the cremaster (when P-selectin does 595 
not play such a dominant role) as well as in response to TNF-α stimulation, that 596 
rolling velocities are significantly increased in ICAM-1 KO mice compared to WT. 597 
These studies and data presented here highlight the complex yet distinct nature of 598 
each step in the leukocyte recruitment cascade.   599 
 600 
Our results in the parallel-plate flow chamber extend the findings of previous studies, 601 
which have focused on the end phase of transmigration. By using intra-vital 602 
microscopy and the parallel plate flow chamber we have been able to identify defects 603 
at earlier stages of the leukocyte recruitment cascade, namely rolling and activation. 604 
We have shown that Gal-3-/- leukocytes did not capture to E-selectin and initiate 605 
downstream changes in their activation state and cell morphology. In order to 606 
investigate this further we examined the availability of E-selectin ligands in the 607 
absence of Gal-3 and determined that Gal-3-/- neutrophils displayed reduced HPA and 608 
PNA lectin binding, indicating that these cells have an altered cell surface 609 
glycophenotype. The importance of post-translational modification of E-selectin 610 
ligands to their functionality was recently demonstrated using mice lacking the 611 
polypeptide GalNAc transferase-1, which generates core-type O-glycan structures 612 
from GalNAc binding to threonine or serine residues in their protein backbone.  613 
Galnt-1-/- mice display reduced P- and E-selectin-mediated rolling, which in turn 614 
reduces adhesion and emigration of leukocytes in these animals; signalling through 615 
syk and thus integrin activation was unaffected, confirming that it is the ability of 616 
ligands to bind rather than downstream pathways, which are impaired (51). Of 617 
particular importance here, Saravanan et al. (2009) found that various glycogens were 618 
differentially expressed in Gal-3-/- mice undergoing a corneal model of wound-619 
healing; these included glycosyltransferases and glycosidases that were down- or 620 
upregulated in order to produce less N-glycans and more O-glycans. For example, an 621 
























downregulated whereas N-acetylgalactosaminyltransferases-3 and -7 (ppGalNAcTs-3 623 
and -7) which initiate O-glycosylation, were upregulated (52).   624 
 625 
It was important to observe that changes in lectin binding were specific with discreet 626 
alterations in HPA and PNA binding emerging from the assay analyses. HPA 627 
selectively binds to α-N-acetylgalactosamine residues and has been extensively 628 
studied as a marker of cancer cell metastasis (53). Another study highlighted the 629 
similar structure of HPA and sLex, hypothesising they may have overlapping but not 630 
identical glycotopes (54), supporting the notion we propose herein that reduced HPA 631 
binding indicates reduced selectin ligand binding. A putative receptor for PNA in 632 
keratinocytes is CD44, a known E-selectin ligand: this leads us to suggest that 633 
although CD44 levels are not reduced in Gal-3-/- leukocytes, they may display reduced 634 
binding capacity due to altered glycosylation (55). 635 
 636 
Overall our results suggest that there are defects in both the endothelial and 637 
haematopoietic compartments in Gal-3-/- mice. This is evidenced by the reduced 638 
recruitment of Gal-3-/- leukocytes in the in vitro flow assay as well as the greater 639 
defect in response to the endothelial-dependent stimulus IL-1β in vivo. One way to 640 
address this issue would be through the generation of bone marrow chimeras, 641 
however we would anticipate from our results that defects in trafficking would be 642 
observed when Gal-3 is absent from either compartment, particularly if a global loss 643 
of Gal-3 results in an altered cellular glycophenotype. One way to address this issue 644 
would be to generate conditional knockout mice, as this would enable the role of 645 
particular cellular sources of Gal-3 to be examined.  646 
 647 
In the second part of this study, we have shown that exogenous Gal-3 elicits an 648 
inflammatory response alone, whereby local administration of recombinant Gal-3 to 649 
WT mice resulted in a dose-dependent reduction in rolling velocity associated with 650 
increased numbers of adherent and emigrated leukocytes, approximately half of which 651 
were Ly6G-positive neutrophils. Intrascrotal administration of Gal-3 to CX3CR1gfp/+ 652 
mice confirmed that approximately equal numbers of monocytes are also recruited in 653 
response to this lectin. These findings are supported by numerous in vitro studies 654 
























and induces their recruitment to a mouse air-pouch model (56). Studies have also 656 
examined the role of Gal-3 in murine models of Streptococcal pneumoniae lung 657 
infection; accumulation of Gal-3 in the lungs correlated with neutrophil emigration to 658 
the alveoli during infection and low levels of Gal-3 were bound to the neutrophil cell 659 
surface.  660 
 661 
Our in vivo data has furthered our knowledge on the role of Gal-3 in leukocyte 662 
recruitment by extending its actions to monocyte recruitment as well as neutrophils. 663 
The effects of Gal-3 on monocyte migration have been further studied in vitro where 664 
this lectin promoted monocyte chemotaxis, a finding replicated for human 665 
macrophages (57).  Of note, Melo et al. found that treatment of Gal-3 null sarcoma 666 
cells with recombinant Gal-3 increased migration on laminin suggesting that any 667 
defects in the cells could be rescued (58). This rescue effect was not apparent in the 668 
current study as treatment of Gal-3-/- leukocytes with physiological levels of 669 
recombinant Gal-3 in the ex vivo flow chamber assays was unable to reverse their 670 
phenotype and did not increase their capture to E-selectin under conditions of flow. 671 
Taken together with our findings that intravenous administration of Gal-3 did not 672 
affect leukocyte recruitment, this provides further evidence that, at least in these 673 
models and with the concentrations used in this study, a global lack of Gal-3 results in 674 
impaired leukocyte function in vivo.   675 
 676 
Rather than acting directly on the leukocytes, the effect of exogenously delivered Gal-677 
3 were indirect, and lead to increased mRNA for IL-1β, TNFα, KC, MCP-1 and IL-6 678 
in the cremaster preparations. With the exception of IL-1β, these results were 679 
confirmed by proteome profile, which also revealed higher levels of IFNγ, MIP-2 and 680 
MIP-1α post-Gal-3. These data point to stromal cells as the plausible target for Gal-3 681 
to initiate a local inflammatory response.  This is consistent with reports in the 682 
literature. Since levels of Gal-3 are increased at sites of joint destruction in RA, Filer 683 
et al. investigated the effect of exogenous Gal-3 treatment of human synovial 684 
fibroblasts, which increased their production of IL-6, GM-CSF, TNFα and MMP-3 as 685 
well as the neutrophil chemoattractant IL-8 and the monocyte chemoattractants MCP-686 
1, MIP-1α and RANTES. The authors established that autocrine TNFα stimulation 687 
























and JNK, p38 MAPK and Akt phosphorylation was evident at 15 min as well as 689 
activation of NFκB (59). The activation of PI3K by Gal-3 has also been demonstrated 690 
in macrophages, which is often associated with chemokine production by stromal 691 
cells (60) as well as E-selectin-dependent neutrophil rolling and trafficking (61), both 692 
cell types that are abundant in the cremaster muscle.   693 
 694 
Taken together these results confirm that Gal-3 is a multi-faceted molecule that 695 
exhibits modulatory properties on many aspects of the inflammatory response; based 696 
on our results, we propose the following model (Fig. 7.) whereby the endogenous 697 
protein functions to potentiate the inflammatory response as evidenced by reduced 698 
adhesion molecule expression and an altered glycosylation profile culminating in a 699 
lack of slow rolling and reduced emigration in response to IL-1β. This is in contrast to 700 
exogenously administered Gal-3, which evokes a tissue-restricted circuit by acting on 701 
stromal cells (plausible ones are fibroblasts, macrophages and endothelial cells) 702 
resulting in an enhanced pro-inflammatory state that culminates in increased levels of 703 
leukocyte trafficking. We propose that full definition of the roles for Gal-3 in 704 
controlling vascular inflammation can help in designing novel approaches for 705 
therapeutic benefit. 706 
 707 
 708 
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Figure Legends 936 
Fig. 1. Endogenous Gal-3 is required for leukocyte slow rolling in response to 937 
TNFα and IL-1β and leukocyte emigration in response to IL-1β in post-capillary 938 
venules.  Cremasteric post-capillary venules of C57BL/6 or Gal-3-/- mice were 939 
analysed by intravital microscopy following intrascrotal injection of TNFα (300ng) or 940 
IL-1β (30ng) 4 hours prior to exteriorisation. (A) leukocyte rolling velocity; (B) no. of 941 
adherent leukocytes (>30s); (C) no. of emigrated leukocytes.  All data were obtained 942 
from segments of 100μm in 3-5 vessels per mouse and 3-5 mice per group. Results 943 
are expressed as mean±SEM for all parameters analysed. Statistical significance was 944 
assessed by two-way ANOVA and with Bonferroni’s multiple comparison post-test; 945 
denoted by asterisks * P<0.05. (D) Representative images from vessels of C57BL/6 946 
(upper panel) or Gal-3-/- mice (lower panel) following vehicle, IL-1β or TNFα 947 
treatment show rolling, adherent and emigrated leukocytes. 948 
 949 
Fig. 2. Leukocyte binding to E-selectin and subsequent cellular morphological 950 
changes are disrupted in the absence of endogenous Gal-3 951 
Murine leukocyte interactions with recombinant E-selectin were examined under 952 
conditions of flow. C57BL/6 or Gal-3-/- whole blood was collected by cardiac 953 
puncture and diluted in HBSS. Blood was flown for 3mins at 1.010ml/min, followed 954 
by 1min HBSS. Videos of 10s were captured for a total of 4-6 frames per mouse and 3 955 
mice per group. Captured leukocytes in each frame were quantified and classified as 956 
phase dark or phase light according to their cellular morphology. The no. of adherent 957 
cells were quantified (A) and the percentage of cells transitioning to phase dark was 958 
calculated for each genotype (B). (C) Representative stills taken from C57BL/6 (left 959 
panel) or Gal-3-/- (right panel) experiments, scale 50µm; higher magnification shown 960 
in inset, scale 10µm. (D) Gal-3-/- whole blood was pre-treated for 15min at 37°C with 961 
recombinant Gal-3 (rGal-3; 10ng/mL) prior to flow. Results are expressed as 962 
mean±SEM. Significance was assessed using an unpaired student’s t-test, denoted by 963 
asterisks * P<0.05.  964 
 965 
Fig. 3. Murine neutrophils display reduced PNA and HPA lectin binding sites on 966 
their cell surface. Wild type or Gal-3-/- whole blood was collected by cardiac 967 
























assessed for their ability to bind the lectins SNA, PNA, MALII, L-PHA and HPA by 969 
flow cytometry.  (B) Representative histogram plot showing PNA lectin binding on 970 
wild type and Gal-3-/- neutrophils, with isotype control (grey).  (C) Representative 971 
histogram plot showing HPA lectin binding on wild type and Gal-3-/- neutrophils, with 972 
isotype control (grey). Results are expressed as mean±SEM of 3-6 mice per group. 973 
Significance was assessed using an unpaired student’s t-test, denoted by asterisks * 974 
P<0.05.  975 
 976 
Fig. 4. Cells lacking endogenous Gal-3 display altered ligand expression 977 
following activation with TNFα and IL-1β.  (A-D) Wild type or Gal-3-/- whole 978 
blood was treated for 10min at 37°C with TNFα (50ng/mL) or IL-1β (50ng/mL) and 979 
CD11b (A) and L-selectin (C) surface expression was assessed by flow cytometry. (B, 980 
D) Representative histogram plots of wild type and Gal-3-/- neutrophils stained for 981 
isotype control (grey) or CD11b (B) or L-selectin (D) after treatment with vehicle 982 
(blue), IL-1β (red line) or TNFα (dark red). (E-F) Confluent wild type and Gal-3-/- 983 
mEC were treated for 4h with IL-1β (1, 50, 100ng/mL) prior to analysis by flow 984 
cytometry. Representative histogram plots showing isotype control (grey tinted), 985 
vehicle (PBS) treated wild type cells (filled pale blue), IL-1β (50ng/mL)-treated wild 986 
type cells (blue line), vehicle (PBS) treated Gal-3-/- cells (filled pale red) and IL-1β 987 
(50ng/mL)-treated Gal-3-/- cells (red line) stained for (E) E-selectin and (F) ICAM-1. 988 
Results are expressed as mean±SEM of 2-4 mice per group, significance was assessed 989 
by two-way ANOVA and Bonferroni’s multiple comparison post-test, denoted by 990 
asterisks * P<0.05, ** P<0.01 and *** P<0.001.  991 
 992 
Fig. 5.  Administration of recombinant Gal-3 results in neutrophil and monocyte 993 
recruitm nt to post-capillary venules. Cremasteric post-capillary venules of 994 
C57BL/6 mice were analysed by intravital microscopy following intrascrotal injection 995 
of rGal-3 (500ng) 2 or 4 hours prior to exteriorisation. (A) leukocyte rolling velocity, 996 
no. of adherent leukocytes (>30s) and no. of emigrated leukocytes. Cremasteric post-997 
capillary venules of CX3CR1gfp/+ mice were assessed 4h after intrascrotal injection of 998 
rGal-3 (1000ng) and GFP-positive monocyte rolling velocity, adhesion and 999 
emigration was analysed (B). (C) Representative images from vessels of CX3CR1gfp/+ 1000 
mice following vehicle or rGal-3 administration, where monocytes are GFP-positive 1001 
























intrascrotal injection of rGal-3 (200-1000ng) and i.v. administration of anti-mouse 1003 
Ly-6G (2μg) to label murine neutrophils. Ly-6G positive cells are shown in the filled 1004 
columns and Ly-6G negative cells in the empty columns. (E) Representative images 1005 
from vessels of C57BL/6 mice following vehicle or rGal-3 administration, where 1006 
neutrophils are stained with anti-mouse Ly-6G (red). (F) Cremasters from 1007 
CX3CR1gfp/+ mice treated intrascrotally for 4h with rGal-3 (1000ng) were exteriorised 1008 
before analysis by confocal microscopy. Representative images from vehicle and 1009 
rGal-3 -treated mice; vessels are stained using VE-Cadherin (Red), MRP14 positive 1010 
neutrophils are blue and GFP positive monocytes are green. (G) Emigrated 1011 
neutrophils and monocytes were quantified.  All data obtained from segments of 1012 
100μm in 3-5 vessels per mouse and 3-5 mice per group. Results are expressed as 1013 
mean±SEM for all parameters analysed.  Statistical significance was assessed by one- 1014 
or two-way ANOVA and with Tukey’s multiple comparison post-test or unpaired 1015 
student’s t-tests; denoted by asterisks * P<0.05. and ** P<0.01 and # P<0.05 and ## 1016 
P<0.01 between Ly-6G+ve bars.   1017 
 1018 
Fig. 6. Administration of recombinant Gal-3 results in increased pro-1019 
inflammatory cytokine and chemokine expression in the local tissue 1020 
microenvironment 1021 
The cremasteric tissue of C57BL/6 mice was assessed 4h after intrascrotal injection of 1022 
PBS or recombinant Gal-3 (1000ng).  (A) Gene expression of IL-1β, TNFα, KC, 1023 
MCP-1, IL-6 and SDF-1 following exogenous Gal-3 treatment.  Results are expressed 1024 
as 2-ΔΔCT where gen  expression is normalised to an internal housekeeping gene 1025 
(GAPDH) and then normalised once more to the sham cremasters. Results are 1026 
displayed as mean±SEM of 2-3 mice per group. (B) Protein content was assessed 1027 
using th  mouse cytokine array panel A Proteome Profiler™ using tissue 1028 
homogenates from cremasters treated with exogenous Gal-3. 1029 
 1030 
 1031 
Fig. 7. Gal-3 is a positive regulator of leukocyte recruitment to the inflamed 1032 
microcirculation. In the absence of endogenous Gal-3 adhesion molecule expression 1033 
is reduced on circulating neutrophils and the vascular endothelium. The glycosylation 1034 
























recognised by the lectins HPA and PNA. These changes correspond with impaired 1036 
slow rolling of leukocytes in response to the cytokines TNFα and IL-1β, with 1037 
transendothelial migration in response to IL-1β also reduced. Conversely, 1038 
administration of recombinant Gal-3 upregulates pro-inflammatory cytokines and 1039 
chemokines, which results in the enhanced recruitment of neutrophils and monocytes 1040 
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